Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2318-2334
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2318
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2318
Figure 7 Schematic diagram of the effect of PD-1/CTLA-4 signaling on the immune microenvironment of gastric cancer.
ICB: Immune checkpoint blockade; ADR: Adverse drug reaction; MHC: Major histocompatibility complex. Created with BioRender.com (see Supplementary material).
- Citation: Jiang YK, Li W, Qiu YY, Yue M. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World J Gastrointest Oncol 2024; 16(6): 2318-2334
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2318.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2318